Betamek Bhd (0263)
Market Closed
11 Aug, 07:49
XKLS 
XNSE Primary XKLS RM
0. 80
-0.03
-4.1916%
RM
- Market Cap
- P/E Ratio
- Div Yield
1.13M Volume
- Eps
RM 0.83
Previous Close Want to track 0263 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
0263 closed today lower at RM0.8, a decrease of -4.1916% from yesterday's close, completing a monthly increase of 26.9841% or RM0.17. Over the past 12 months, 0263 stock gained 58.4158%.
0263 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
0263 Chart
Betamek Bhd (0263) FAQ
What is the stock price today?
The current price is RM0.80.
On which exchange is it traded?
Betamek Bhd is listed on XKLS.
What is its stock symbol?
The ticker symbol is 0263.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Betamek Bhd ever had a stock split?
No, there has never been a stock split.
Betamek Bhd Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | XKLS Exchange | MYQ0263OO002 ISIN |
| India Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Beta Drugs Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical formulations. The company specializes in the production of oncology products, playing a crucial role in the healthcare sector by addressing the complex needs of cancer treatment. Leveraging cutting-edge technology and research, Beta Drugs Ltd. offers a diverse portfolio of therapeutic solutions that cater to oncology-specific demands, contributing significantly to the advancement of medical treatments in this critical field.
The company impacts both domestic and international markets by exporting high-quality pharmaceuticals, thus enhancing its global footprint. Beta Drugs Ltd. operates within a highly regulated environment, ensuring that its products meet stringent quality standards to ensure patient safety and efficacy. Its participation in the pharmaceutical market is vital, as it supports healthcare systems with innovative solutions that improve patient outcomes and elevate standards of care.
Contact Information
Address: -
Phone: -
